Source:http://linkedlifedata.com/resource/pubmed/id/17608141
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2007-7-4
|
pubmed:abstractText |
Immunological activation has been proposed to play a role in methamphetamine-induced dopaminergic terminal damage. In this study, we examined the roles of lipopolysaccharide, a pro-inflammatory and inflammatory factor, treatment in modulating the methamphetamine-induced nigrostriatal dopamine neurotoxicity. Lipopolysaccharide pretreatment did not affect the basal body temperature or methamphetamine-elicited hyperthermia three days later. Such systemic lipopolysaccharide treatment mitigated methamphetamine-induced striatal dopamine and 3,4-dihydroxyphenylacetic acid depletions in a dose-dependent manner. As the most potent dose (1 mg/kg) of lipopolysaccharide was administered two weeks, one day before or after the methamphetamine dosing regimen, methamphetamine-induced striatal dopamine and 3,4-dihydroxyphenylacetic acid depletions remained unaltered. Moreover, systemic lipopolysaccharide pretreatment (1 mg/kg) attenuated local methamphetamine infusion-produced dopamine and 3,4-dihydroxyphenylacetic acid depletions in the striatum, indicating that the protective effect of lipopolysaccharide is less likely due to interrupted peripheral distribution or metabolism of methamphetamine. We concluded a critical time window for systemic lipopolysaccharide pretreatment in exerting effective protection against methamphetamine-induced nigrostriatal dopamine neurotoxicity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3,4-Dihydroxyphenylacetic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Lipopolysaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Methamphetamine,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Dopamine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0304-4920
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
30
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
51-6
|
pubmed:dateRevised |
2009-8-12
|
pubmed:meshHeading |
pubmed-meshheading:17608141-3,4-Dihydroxyphenylacetic Acid,
pubmed-meshheading:17608141-Animals,
pubmed-meshheading:17608141-Basal Ganglia,
pubmed-meshheading:17608141-Body Temperature,
pubmed-meshheading:17608141-Dopamine,
pubmed-meshheading:17608141-Dopamine Agents,
pubmed-meshheading:17608141-Dose-Response Relationship, Drug,
pubmed-meshheading:17608141-Drug Synergism,
pubmed-meshheading:17608141-Fever,
pubmed-meshheading:17608141-Lipopolysaccharides,
pubmed-meshheading:17608141-Male,
pubmed-meshheading:17608141-Methamphetamine,
pubmed-meshheading:17608141-Mice,
pubmed-meshheading:17608141-Mice, Inbred C57BL,
pubmed-meshheading:17608141-Neurons,
pubmed-meshheading:17608141-Neuroprotective Agents,
pubmed-meshheading:17608141-Receptors, Dopamine
|
pubmed:year |
2007
|
pubmed:articleTitle |
Attenuation of methamphetamine-induced nigrostriatal dopaminergic neurotoxicity in mice by lipopolysaccharide pretreatment.
|
pubmed:affiliation |
Institute of Behavioral Medicine, National Cheng-Kung University College of Medicine Tainan 701, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|